Last reviewed · How we verify
NCT05238168: ePIPARI
Evaluation of Digital Follow up of Preterm Infants
trial testing ePIPARI digital follow up tool in Preterm Birth in 70 participants. Status unknown.
30 April 2025
Quick facts
| Lead sponsor | Turku University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 January 2019 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 April 2025 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- ePIPARI digital follow up tool
Conditions studied
- Preterm Birth — all drugs for Preterm Birth →
- Development Delay — all drugs for Development Delay →
- Sensory Disorder — all drugs for Sensory Disorder →
- Growth Disorders — all drugs for Growth Disorders →
Sponsor
Turku University Hospital
Who can join
Adults 1 Month to 28 Months, any sex, with Preterm Birth or Development Delay. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to study how a digital follow up tool can identify the preterm born children and their families who need further support or clinical interventions
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Web-based follow-up tool (ePIPARI) of preterm infants-study protocol for feasibility and performance.
Saarinen T, Ylijoki M, Lehtonen L, Munck P, et al · · 2023 · PMID 37612695 · DOI 10.1186/s12887-023-04226-4
Verify or expand the search:
- PubMed search for NCT05238168
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Birth
Currently open trials in the same condition.
- NCT07265583 — Early Prediction of Lung Injury in Preterm Infants Score · recruiting
- NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
- NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
- NCT06826859 — Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) · Phase 1, PHASE2 · recruiting
- NCT07231432 — Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India · NA · active not recruiting
Other Turku University Hospital trials
Trials by the same sponsor.
- NCT07488494 — Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (E · NA · not yet recruiting
- NCT07316868 — Neuroprotective Effect of Mild Hypothermia Versus Normothermia During Cardiopulmonary Bypass of Coronary Artery Surgery · NA · not yet recruiting
- NCT07306000 — Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development · NA · recruiting
- NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
- NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05238168 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Turku University Hospital
- Last refreshed: 19 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05238168.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing